Efficacy News and Research

RSS
Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS

Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS

GUVAX reports successful results in phase I study of oral, Escherichia coli diarrhea vaccine

GUVAX reports successful results in phase I study of oral, Escherichia coli diarrhea vaccine

A1-PI treatment slows progression of emphysema in patients with AATD

A1-PI treatment slows progression of emphysema in patients with AATD

Naloxegol meets primary and secondary endpoints in two pivotal Phase III studies

Naloxegol meets primary and secondary endpoints in two pivotal Phase III studies

Boehringer Ingelheim's tiotropium shows promising results in patients with severe persistent asthma

Boehringer Ingelheim's tiotropium shows promising results in patients with severe persistent asthma

Study reinforces efficacy of NeuroStar TMS Therapy System in patients with MDD

Study reinforces efficacy of NeuroStar TMS Therapy System in patients with MDD

Studies show that LipiGesic M provides highly effective OTC solution to migraine pain

Studies show that LipiGesic M provides highly effective OTC solution to migraine pain

Gilead Sciences' sofosbuvir MAA gets EMA validation

Gilead Sciences' sofosbuvir MAA gets EMA validation

Alzheimer's disease: Researchers find new drug to prevent, treat the disease

Alzheimer's disease: Researchers find new drug to prevent, treat the disease

COPD patients are more oliley to suffre from depression

COPD patients are more oliley to suffre from depression

Improving health care, reducing costs possible by breaking up physicians and drug company relationship

Improving health care, reducing costs possible by breaking up physicians and drug company relationship

Pfizer halts Phase 3 open-label, two-arm study of lymphoma drug

Pfizer halts Phase 3 open-label, two-arm study of lymphoma drug

Biogen Idec seeks FDA BLA approval for PLEGRIDY to treat multiple sclerosis

Biogen Idec seeks FDA BLA approval for PLEGRIDY to treat multiple sclerosis

Research explores pharmaceutical advances for IBS, hepatitis C

Research explores pharmaceutical advances for IBS, hepatitis C

Lung Volume Reduction Coil may play key role in treatment of emphysema, study finds

Lung Volume Reduction Coil may play key role in treatment of emphysema, study finds

XenoPort's Arbaclofen placarbil fails to meet co-primary endpoints in Phase 3 clinical trial

XenoPort's Arbaclofen placarbil fails to meet co-primary endpoints in Phase 3 clinical trial

Cell Therapeutics announces issuance of final benefit assessment report for PIXUVRI

Cell Therapeutics announces issuance of final benefit assessment report for PIXUVRI

Joint replacement surgery might be avoidable in the future, suggest scientists

Joint replacement surgery might be avoidable in the future, suggest scientists

Patients with treatment-resistant depression benefit from ketamine

Patients with treatment-resistant depression benefit from ketamine

Takeda, Lundbeck announce presentation of data from four studies that evaluate vortioxetine for MDD

Takeda, Lundbeck announce presentation of data from four studies that evaluate vortioxetine for MDD

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.